Biologic and Clinical Perspectives on Thyroid Cancer

被引:658
作者
Fagin, James A. [1 ,2 ]
Wells, Samuel A., Jr. [3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA
[3] NCI, Genet Branch, Bldg 37,Rm 6138,37 Convent Dr, Bethesda, MD 20892 USA
关键词
TERT PROMOTER MUTATIONS; RADIOACTIVE IODINE; BRAF V600E; FEEDBACK INHIBITION; SERUM CALCITONIN; DOUBLE-BLIND; RET FUSION; FOLLOW-UP; CARCINOMA; NODULES;
D O I
10.1056/NEJMra1501993
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent discoveries in molecular medicine, coupled with advances in biotechnology and medicinal chemistry, have led to enormous progress in the diagnosis and treatment of patients with thyroid cancer. We have no doubt that this progress will continue with the development of more effective therapies that are based on new compounds with greater specificity for oncogenic targets and combinatorial regimens that overcome resistance to single agents. © 2016 Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:1054 / 1067
页数:14
相关论文
共 88 条
[1]   Integrated Genomic Characterization of Papillary Thyroid Carcinoma [J].
Agrawal, Nishant ;
Akbani, Rehan ;
Aksoy, B. Arman ;
Ally, Adrian ;
Arachchi, Harindra ;
Asa, Sylvia L. ;
Auman, J. Todd ;
Balasundaram, Miruna ;
Balu, Saianand ;
Baylin, Stephen B. ;
Behera, Madhusmita ;
Bernard, Brady ;
Beroukhim, Rameen ;
Bishop, Justin A. ;
Black, Aaron D. ;
Bodenheimer, Tom ;
Boice, Lori ;
Bootwalla, Moiz S. ;
Bowen, Jay ;
Bowlby, Reanne ;
Bristow, Christopher A. ;
Brookens, Robin ;
Brooks, Denise ;
Bryant, Robert ;
Buda, Elizabeth ;
Butterfield, Yaron S. N. ;
Carling, Tobias ;
Carlsen, Rebecca ;
Carter, Scott L. ;
Carty, Sally E. ;
Chan, Timothy A. ;
Chen, Amy Y. ;
Cherniack, Andrew D. ;
Cheung, Dorothy ;
Chin, Lynda ;
Cho, Juok ;
Chu, Andy ;
Chuah, Eric ;
Cibulskis, Kristian ;
Ciriello, Giovanni ;
Clarke, Amanda ;
Clayman, Gary L. ;
Cope, Leslie ;
Copland, John A. ;
Covington, Kyle ;
Danilova, Ludmila ;
Davidsen, Tanja ;
Demchok, John A. ;
DiCara, Daniel ;
Dhalla, Noreen .
CELL, 2014, 159 (03) :676-690
[2]   Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology [J].
Alexander, Erik K. ;
Kennedy, Giulia C. ;
Baloch, Zubair W. ;
Cibas, Edmund S. ;
Chudova, Darya ;
Diggans, James ;
Friedman, Lyssa ;
Kloos, Richard T. ;
LiVolsi, Virginia A. ;
Mandel, Susan J. ;
Raab, Stephen S. ;
Rosai, Juan ;
Steward, David L. ;
Walsh, P. Sean ;
Wilde, Jonathan I. ;
Zeiger, Martha A. ;
Lanman, Richard B. ;
Haugen, Bryan R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (08) :705-715
[3]   RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation [J].
Ballerini, P. ;
Struski, S. ;
Cresson, C. ;
Prade, N. ;
Toujani, S. ;
Deswarte, C. ;
Dobbelstein, S. ;
Petit, A. ;
Lapillonne, H. ;
Gautier, E-F ;
Demur, C. ;
Lippert, E. ;
Pages, P. ;
Mansat-De Mas, V. ;
Donadieu, J. ;
Huguet, F. ;
Dastugue, N. ;
Broccardo, C. ;
Perot, C. ;
Delabesse, E. .
LEUKEMIA, 2012, 26 (11) :2384-2389
[4]   Treating advanced radioresistant differentiated thyroid cancer [J].
Bible, Keith C. .
LANCET ONCOLOGY, 2012, 13 (09) :854-855
[5]   Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study [J].
Bible, Keith C. ;
Suman, Vera J. ;
Molina, Julian R. ;
Smallridge, Robert C. ;
Maples, William J. ;
Menefee, Michael E. ;
Rubin, Joseph ;
Sideras, Kostandinos ;
Morris, John C., III ;
McIver, Bryan ;
Burton, Jill K. ;
Webster, Kevin P. ;
Bieber, Carolyn ;
Traynor, Anne M. ;
Flynn, Patrick J. ;
Goh, Boon Cher ;
Tang, Hui ;
Ivy, Susan Percy ;
Erlichman, Charles .
LANCET ONCOLOGY, 2010, 11 (10) :962-972
[6]   Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma [J].
Bollag, Gideon ;
Hirth, Peter ;
Tsai, James ;
Zhang, Jiazhong ;
Ibrahim, Prabha N. ;
Cho, Hanna ;
Spevak, Wayne ;
Zhang, Chao ;
Zhang, Ying ;
Habets, Gaston ;
Burton, ElizabethA. ;
Wong, Bernice ;
Tsang, Garson ;
West, Brian L. ;
Powell, Ben ;
Shellooe, Rafe ;
Marimuthu, Adhirai ;
Nguyen, Hoa ;
Zhang, Kam Y. J. ;
Artis, Dean R. ;
Schlessinger, Joseph ;
Su, Fei ;
Higgins, Brian ;
Iyer, Raman ;
D'Andrea, Kurt ;
Koehler, Astrid ;
Stumm, Michael ;
Lin, Paul S. ;
Lee, Richard J. ;
Grippo, Joseph ;
Puzanov, Igor ;
Kim, Kevin B. ;
Ribas, Antoni ;
McArthur, Grant A. ;
Sosman, Jeffrey A. ;
Chapman, Paul B. ;
Flaherty, Keith T. ;
Xu, Xiaowei ;
Nathanson, Katherine L. ;
Nolop, Keith .
NATURE, 2010, 467 (7315) :596-599
[7]   Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial [J].
Brose, Marcia S. ;
Nutting, Christopher M. ;
Jarzab, Barbara ;
Elisei, Rossella ;
Siena, Salvatore ;
Bastholt, Lars ;
de la Fouchardiere, Christelle ;
Pacini, Furio ;
Paschke, Ralf ;
Shong, Young Kee ;
Sherman, Steven I. ;
Smit, Johannes W. A. ;
Chung, John ;
Kappeler, Christian ;
Pena, Carol ;
Molnar, Istvan ;
Schlumberger, Martin J. .
LANCET, 2014, 384 (9940) :319-328
[8]  
Brose MS., 2016, The Lancet Oncology
[9]  
CECCHERINI I, 1994, J ENDOCRINOL INVEST, V17, P201
[10]   Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation [J].
Chakravarty, Debyani ;
Santos, Elmer ;
Ryder, Mabel ;
Knauf, Jeffrey A. ;
Liao, Xiao-Hui ;
West, Brian L. ;
Bollag, Gideon ;
Kolesnick, Richard ;
Thin, Tin Htwe ;
Rosen, Neal ;
Zanzonico, Pat ;
Larson, Steven M. ;
Refetoff, Samuel ;
Ghossein, Ronald ;
Fagin, James A. .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (12) :4700-4711